Evaluation of pharmacokinetic interactions between longacting cabotegravir or emtricitabinetenofovir disoproxil fumarate and hormonal contraceptive agents a tertiary analysis of South African participants in HPTN 084

Simple item page
dc.article.end-page11en
dc.article.start-page1en
dc.citation.doi10.1002/JIA2.70056en
dc.contributor.authorMark A. Marzinkeen
dc.contributor.authorBrett Hanscomen
dc.contributor.authorDaniel Hainesen
dc.contributor.authorKimberly K. Scarsien
dc.contributor.authorYaw Agyeien
dc.contributor.authorCarrie-Anne Mathewen
dc.contributor.authorE et alen
dc.contributor.authorAnn Delany-Moretlween
dc.date.accessioned2026-03-26T13:22:46Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.urihttps://hdl.handle.net/10539/48733
dc.journal.titleEvaluation of pharmacokinetic interactions between longacting cabotegravir or emtricitabinetenofovir disoproxil fumarate and hormonal contraceptive agents a tertiary analysis of South African participants in HPTN 084en
dc.journal.volume28en
dc.publisherINT AIDS SOCIETYen
dc.titleEvaluation of pharmacokinetic interactions between longacting cabotegravir or emtricitabinetenofovir disoproxil fumarate and hormonal contraceptive agents a tertiary analysis of South African participants in HPTN 084en
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
880.87 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)